You are here

Clinical Trials: Heart Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, October 6, 2021 - 12:00
Condition:   Chronic Ischemic Left Ventricular Dysfunction
Interventions:   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells;   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells;   Drug: Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells
Sponsor:   Joseph C. Wu
Not yet recruiting
Posted: Tuesday, September 14, 2021 - 12:00
Conditions:   Myocardial Infarction, Acute;   Myocardial Infarction First;   Myocardial Infarction, Anterior Wall;   Cardiac Remodeling, Ventricular;   STEMI;   Regenerative Medicine;   Heart Failure
Interventions:   Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs);   Other: Conventional Treatment
Sponsors:   Shiraz University of Medical Sciences;   National Institute of Medical Research Development (NIMAD), Iran;   Cell Tech Pharmed Company, Iran
Recruiting
Posted: Monday, August 9, 2021 - 12:00
Conditions:   Ischemic Heart Disease;   Lung Injury;   Non-cardiac Surgery
Interventions:   Biological: human umbilical cord-derived mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, August 5, 2021 - 12:00
Condition:   Heart Failure, Systolic
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Other: human serum albumin
Sponsor:   Shanghai East Hospital
Not yet recruiting
Posted: Friday, June 25, 2021 - 12:00
Conditions:   Myocardial Ischemia;   Ventricular Dysfunction, Left
Intervention:   Biological: Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Condition:   Hypoplastic Left Heart Syndrome
Intervention:   Biological: Lomecel-B medicinal signaling cells
Sponsors:   Ann & Robert H Lurie Children's Hospital of Chicago;   National Heart, Lung, and Blood Institute (NHLBI);   The University of Texas Health Science Center, Houston;   Longeveron Inc.
Recruiting
Posted: Monday, June 14, 2021 - 12:00
Condition:   Heart Transplantation
Intervention:   Biological: Autologous thyTreg
Sponsors:   Rafael Correa-Rocha;   Instituto de Salud Carlos III;   Fundación Familia Alonso
Recruiting
Posted: Friday, May 28, 2021 - 12:00
Condition:   Congenital Heart Disease, SRV Dependent
Intervention:   Biological: Autologous mononuclear cells
Sponsors:   Timothy J Nelson, MD, PhD;   Mayo Clinic;   University of Oklahoma;   Children's Hospital of Philadelphia;   Children's Hospital Los Angeles;   Children's Hospitals and Clinics of Minnesota;   Children's Hospital Colorado;   Ochsner Health System;   Children's of Alabama;   Children's Hospital Medical Center, Cincinnati;   The Hospital for Sick Children
Not yet recruiting
Posted: Thursday, May 27, 2021 - 12:00
Condition:   Acute Coronary Syndrome
Intervention:   Genetic: PLIN1 gene sequencing
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
Posted: Monday, March 1, 2021 - 12:00
Conditions:   Diabetes Mellitus;   Ischemic Heart Disease
Interventions:   Drug: 100 million Allogeneic Mesenchymal Human Stem Cells;   Other: Placebo
Sponsors:   Joshua M Hare;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Pages